Standard BioTools Inc. (NASDAQ:LAB) Q4 2022 Earnings Call Transcript
Operator: Hello, and welcome to the Standard BioTools Inc. Fourth Quarter and Full Year 2022 Financial Results Conference Call. As a reminder, this conference is being recorded.
Stay updated with breaking news from Michael Egholm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Hello, and welcome to the Standard BioTools Inc. Fourth Quarter and Full Year 2022 Financial Results Conference Call. As a reminder, this conference is being recorded.
Fourth quarter 2022 GAAP revenues of $27.0 million; Core product and service revenues of $26.8 million, representing 8.3% sequential growth; Full year GAAP...
13.10.2022 - SOUTH SAN FRANCISCO, Calif., Oct. 13, 2022 (GLOBE NEWSWIRE) - Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today announced that Ascendas Genomics has received ... Seite 1
South San Francisco, Calif. (PRWEB) October 11, 2022 -- SOUTH SAN FRANCISCO, Calif., October 11, 2022 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB),
Standard BioTools Announces Second Quarter 2022 Financial Results and Provides Strategic Update Second quarter revenue of $18.8 million Completed $250 million... | August 8, 2022